134 related articles for article (PubMed ID: 12680148)
1. Bag-1 expression in thyroid neoplasm: its correlation with Bcl-2 expression and carcinoma dedifferentiation.
Ito Y; Yoshida H; Nakano K; Takamura Y; Miya A; Kobayashi K; Yokozawa T; Matsuzuka F; Matsuura N; Kakudo K; Kuma K; Miyauchi A
Anticancer Res; 2003; 23(1B):569-76. PubMed ID: 12680148
[TBL] [Abstract][Full Text] [Related]
2. Expression of bcl-2, c-erbB-2, p53, and p21 (waf1-cip1) protein in thyroid carcinomas.
Soda G; Antonaci A; Bosco D; Nardoni S; Melis M
J Exp Clin Cancer Res; 1999 Sep; 18(3):363-7. PubMed ID: 10606183
[TBL] [Abstract][Full Text] [Related]
3. Survivin expression is significantly linked to the dedifferentiation of thyroid carcinoma.
Ito Y; Yoshida H; Uruno T; Nakano K; Miya A; Kobayashi K; Yokozawa T; Matsuzuka F; Matsuura N; Kakudo K; Kuma K; Miyauchi A
Oncol Rep; 2003; 10(5):1337-40. PubMed ID: 12883703
[TBL] [Abstract][Full Text] [Related]
4. Decreased expression of p107 is correlated with anaplastic transformation in papillary carcinoma of the thyroid.
Ito Y; Yoshida H; Tomoda C; Uruno T; Takamura Y; Miya A; Kobayashi K; Matsuzuka F; Kuma K; Miyauchi A
Anticancer Res; 2003; 23(5A):3819-24. PubMed ID: 14666683
[TBL] [Abstract][Full Text] [Related]
5. Expression of S100A2 and S100A6 in thyroid carcinomas.
Ito Y; Yoshida H; Tomoda C; Uruno T; Miya A; Kobayashi K; Matsuzuka F; Kakudo K; Kuma K; Miyauchi A
Histopathology; 2005 May; 46(5):569-75. PubMed ID: 15842639
[TBL] [Abstract][Full Text] [Related]
6. S100A10 expression in thyroid neoplasms originating from the follicular epithelium: contribution to the aggressive characteristic of anaplastic carcinoma.
Ito Y; Arai K; Nozawa R; Yoshida H; Higashiyama T; Takamura Y; Miya A; Kobayashi K; Kuma K; Miyauchi A
Anticancer Res; 2007; 27(4C):2679-83. PubMed ID: 17695432
[TBL] [Abstract][Full Text] [Related]
7. Expression and clinical role of antiapoptotic proteins of the bag, heat shock, and Bcl-2 families in effusions, primary tumors, and solid metastases in ovarian carcinoma.
Elstrand MB; Kleinberg L; Kohn EC; Tropé CG; Davidson B
Int J Gynecol Pathol; 2009 May; 28(3):211-21. PubMed ID: 19620938
[TBL] [Abstract][Full Text] [Related]
8. S100A9 expression is significantly linked to dedifferentiation of thyroid carcinoma.
Ito Y; Arai K; Ryushi ; Nozawa ; Yoshida H; Tomoda C; Uruno T; Miya A; Kobayashi K; Matsuzuka F; Kuma K; Kakudo K; Miyauchi A
Pathol Res Pract; 2005; 201(8-9):551-6. PubMed ID: 16259107
[TBL] [Abstract][Full Text] [Related]
9. Bag-1 expression as a prognostic factor in tongue squamous cell carcinomas.
Xie X; Clausen OP; Boysen M
Laryngoscope; 2004 Oct; 114(10):1785-90. PubMed ID: 15454773
[TBL] [Abstract][Full Text] [Related]
10. The expression and role of serum response factor in papillary carcinoma of the thyroid.
Kim HJ; Kim KR; Park HS; Jang KY; Chung MJ; Shong M; Moon WS
Int J Oncol; 2009 Jul; 35(1):49-55. PubMed ID: 19513551
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein e expression in anaplastic thyroid carcinoma.
Ito Y; Takano T; Miyauchi A
Oncology; 2006; 71(5-6):388-93. PubMed ID: 17690558
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical expression of cyclin D1, E2F-1, and Ki-67 in benign and malignant thyroid lesions.
Saiz AD; Olvera M; Rezk S; Florentine BA; McCourty A; Brynes RK
J Pathol; 2002 Oct; 198(2):157-62. PubMed ID: 12237874
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical analysis of nm23 protein expression in thyroid papillary carcinoma and follicular neoplasm.
Tabriz HM; Adabi Kh; Lashkari A; Heshmat R; Haghpanah V; Larijani B; Tavangar SM
Pathol Res Pract; 2009; 205(2):83-7. PubMed ID: 18996649
[TBL] [Abstract][Full Text] [Related]
14. Telomerase activity in thyroid neoplasms evaluated by the expression of human telomerase reverse transcriptase (hTERT).
Ito Y; Yoshida H; Tomoda C; Uruno T; Takamura Y; Miya A; Kobayashi K; Matsuzuka F; Kuma K; Miyauchi A
Anticancer Res; 2005; 25(1B):509-14. PubMed ID: 15816620
[TBL] [Abstract][Full Text] [Related]
15. The role of cell cycle regulatory protein, cyclin D1, in the progression of thyroid cancer.
Wang S; Lloyd RV; Hutzler MJ; Safran MS; Patwardhan NA; Khan A
Mod Pathol; 2000 Aug; 13(8):882-7. PubMed ID: 10955455
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical analysis of expression of bcl-2 protein in papillary carcinomas and papillary microcarcinomas of the thyroid gland.
Mitselou A; Peschos D; Dallas P; Charalabopoulos K; Agnantis NJ; Vougiouklakis T
Exp Oncol; 2004 Dec; 26(4):282-6. PubMed ID: 15627060
[TBL] [Abstract][Full Text] [Related]
17. KAI1 expression in thyroid neoplasms: its linkage with clinicopathologic features in papillary carcinoma.
Ito Y; Yoshida H; Uruno T; Nakano K; Takamura Y; Miya A; Kobayashi K; Yokozawa T; Matsuzuka F; Kuma K; Miyauchi A
Pathol Res Pract; 2003; 199(2):79-83. PubMed ID: 12747469
[TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferator activated receptor gamma immunohistochemical expression in human papillary thyroid carcinoma tissues. Possible relationship to lymph node metastasis.
Galusca B; Dumollard JM; Chambonniere ML; Germain N; Prades JM; Péoc'h M; Estour B
Anticancer Res; 2004; 24(3b):1993-7. PubMed ID: 15274390
[TBL] [Abstract][Full Text] [Related]
19. Expression of p57/Kip2 protein in normal and neoplastic thyroid tissues.
Ito Y; Yoshida H; Nakano K; Kobayashi K; Yokozawa T; Hirai K; Matsuzuka F; Matsuura N; Kuma K; Miyauchi A
Int J Mol Med; 2002 Apr; 9(4):373-6. PubMed ID: 11891530
[TBL] [Abstract][Full Text] [Related]
20. [Expression of protooncogene bcl-2 in thyroid tumors].
Zhu J; Chen Y; Xue H
Zhonghua Yi Xue Za Zhi; 1996 Nov; 76(11):829-31. PubMed ID: 9275533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
